{"id":243771,"date":"2013-06-21T10:44:40","date_gmt":"2013-06-21T14:44:40","guid":{"rendered":"http:\/\/www.eugenesis.com\/the-american-society-for-microbiology-honors-george-l-drusano\/"},"modified":"2013-06-21T10:44:40","modified_gmt":"2013-06-21T14:44:40","slug":"the-american-society-for-microbiology-honors-george-l-drusano","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/microbiology\/the-american-society-for-microbiology-honors-george-l-drusano.php","title":{"rendered":"The American Society for Microbiology honors George L. Drusano"},"content":{"rendered":"<p><p>Public  release date: 20-Jun-2013  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Garth Hogan    <a href=\"mailto:ghogan@asmusa.org\">ghogan@asmusa.org<\/a>    202-942-9389    American    Society for Microbiology<\/p>\n<p>    The winner of the esteemed Cubist-ICAAC Award is George L.    Drusano, M.D., Institute for Therapeutic Innovation of the    University of Florida, for his application of pharmacokinetic    and pharmacodynamic modeling to antiviral and antimicrobial    drug development. According to his nominator, Michael Dudley,    Rempex Pharmaceuticals, \"Drusano and his colleagues have    published groundbreaking work using    pharmacokinetics\/pharmacodynamics to simulate and then validate    dosing regimens to maximize the safety and efficacy of    antibiotics. The breadth and importance of his work is    remarkable.\"  <\/p>\n<p>    After graduating magna cum laude,  from the Honors Program    at Boston College, Drusano received his M.D. from the    University of Maryland School of Medicine where he graduated    cum laude, . He completed his medical internship and    residency at the University of Maryland Hospital, where he was    Chief Resident and also a Fellow in Medicine in Infectious    Diseases.  <\/p>\n<p>    Drusano, a Fellow of the American Academy of Microbiology and    the Infectious Diseases Society of America (IDSA), is an active    reviewer and has served as editor of the section of    pharmacology and experimental therapeutics for Antimicrobial    Agents and Chemotherapy for 10 years. Currently he is an Editor    for mBio. He has authored over 290 articles.  <\/p>\n<p>    Also an active volunteer, Drusano was a member of the    Interscience Conference on Antimicrobial Agents and    Chemotherapeutics (ICAAC) Program Committee and the IDSA    Program Committee. He has served on multiple National Institute    of Allergy and Infectious Diseases (NIAID) Review Groups and as    an ad hoc member of NIAID Council on two occasions to support    issues regarding emergence of bacterial resistance. He also    serves as a consultant to NIAID and CDC on Biodefense issues.    Drusano has been a member of the Subcommittee on Guidelines for    Bacteremia and Endocarditis of the Antimicrobial Agents Use    Committee, a joint effort of the IDSA and the Food and Drug    Administration. In 2010, he was Chair of the Gordon Conference    on New Antimicrobial Discovery and Development. He has won a    number of awards, including being named Distinguished    Investigator of the Year (2003) by the American College of    Clinical Pharmacology. Most recently, he was named recipient of    the Maxwell Finland Award for Scientific Achievement for 2012    from the National Foundation for Infectious Diseases.  <\/p>\n<p>    An active researcher, Drusano has focused on mathematical    modeling and the pharmacodynamics of anti-infective    chemotherapy, especially the pharmacodynamics of    fluoroquinolone antimicrobials, anti-tuberculosis agents,    multiple anti-viral agents and the therapy of biodefense    pathogens. Paul G. Ambrose, Institute for Clinical    Pharmacodynamics, says, \"Drusano is a distinguished scholar and    scientist who pioneered work in anti-infective pharmacology and    antimicrobial resistance, and helped redefine infectious    disease chemotherapy as we know it today.\"  <\/p>\n<p>    ###  <\/p>\n<p>    The Cubist-ICAAC Award will be presented during ASM's 53rd    Interscience Conference on Antimicrobial Agents and    Chemotherapy (ICAAC), September 10-13, 2013 in Denver,    Colorado. ASM is the world's oldest and largest life science    organization and has more than 40,000 members worldwide. ASM's    mission is to advance the microbiological sciences and promote    the use of scientific knowledge for improved health, economic,    and environmental well-being.  <\/p>\n<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2013-06\/asfm-tas_2062013.php\" title=\"The American Society for Microbiology honors George L. Drusano\">The American Society for Microbiology honors George L. Drusano<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 20-Jun-2013 [ | E-mail | Share ] Contact: Garth Hogan <a href=\"mailto:ghogan@asmusa.org\">ghogan@asmusa.org<\/a> 202-942-9389 American Society for Microbiology The winner of the esteemed Cubist-ICAAC Award is George L. Drusano, M.D., Institute for Therapeutic Innovation of the University of Florida, for his application of pharmacokinetic and pharmacodynamic modeling to antiviral and antimicrobial drug development <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/microbiology\/the-american-society-for-microbiology-honors-george-l-drusano.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577473],"tags":[],"class_list":["post-243771","post","type-post","status-publish","format-standard","hentry","category-microbiology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/243771"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=243771"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/243771\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=243771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=243771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=243771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}